STTR Phase I: A Novel Biosensing Device for Rapidly Mapping Volumetric Tumor Margins — NSF Award to BULLSEYE BIODEVICES, INC. (NJ,
The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is a novel sensor to better detect tumor margins during surgical interventions for cancer. Cancer remains a substantial global healthcare burden due to high treatment costs, long-term care needs, and reduced qualit
| Award title | STTR Phase I: A Novel Biosensing Device for Rapidly Mapping Volumetric Tumor Margins |
|---|---|
| Award ID | 2451826 |
| Awardee | BULLSEYE BIODEVICES, INC. |
| City | JERSEY CITY |
| State | NJ |
| Amount obligated | $305,000 |
| Principal investigator | Mohammad Mir |
| Program | STTR Phase I |
| Start date | 10/01/2025 |
| Abstract | The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is a novel sensor to better detect tumor margins during surgical interventions for cancer. Cancer remains a substantial global healthcare burden due to high treatment costs, long-term care needs, and reduced quality of life. The limitations of existing sensor technologies include challenges with identifying tumor location or boundaries, often resulting in incomplete tumor removal. Inadequate |
| Source | NSF Awards |
$799/mo
Try NSFGrants →